Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

MLA

Fabbri, Leonardo M., et al. “Roflumilast in Moderate-to-Severe Chronic Obstructive Pulmonary Disease Treated with Longacting Bronchodilators: Two Randomised Clinical Trials.” The Lancet, vol. 374, Aug. 2009, pp. 695–703. EBSCOhost, https://doi.org/10.1016/s0140-6736(09)61252-6.

APA

Fabbri, L. M., Calverley, P. M. A., Jose Luis Izquierdo Alonso, Bundschuh, D. S., Manja, B., Martinez, F. J., Rabe, K. M., Study Groups Abdulla, M., Abdullah, I., Adler, M., Aguilaniu, Albert, I., Almonacid, C., Altés, A., Amaducci, S., Angrill, J., Antonana, J. M., Artner, H., Balint, B., … Harper, O. (2009). Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. The Lancet, 374, 695–703. https://doi.org/10.1016/s0140-6736(09)61252-6

Chicago

Fabbri, Leonardo M., Peter M. A. Calverley, Jose Luis Izquierdo Alonso, Daniela S. Bundschuh, Brose Manja, Fernando J. Martinez, Kf M. Rabe, et al. 2009. “Roflumilast in Moderate-to-Severe Chronic Obstructive Pulmonary Disease Treated with Longacting Bronchodilators: Two Randomised Clinical Trials.” The Lancet 374 (August): 695–703. doi:10.1016/s0140-6736(09)61252-6.